View source for Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.5

{{ReferenceData
|has_document=Document:ICH ICH E6 Guideline R3 (2025)
|module=2
|unit=2.3.4
|scope=G
|doc_part=III. Annex 1
3.5
|language=EN
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00111-Agr-chr ++ TAG-00017-Spo-die ++ TAG-00343-Doc-ten ++ TAG-00018-Inv-die
|tags_display=[[Glossary:TAG-00111-Agr-chr|Written agreement]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00343-Doc-ten|Documentation]], [[Glossary:TAG-00018-Inv-die|Investigator]]
|comment=Financial documentation and agreements between sponsor and investigator
|content=3.5 Financing 
The financial aspects of the trial should be documented in an agreement between the sponsor and the investigator/institution.
}}